
Brickell Biotech BBI
Geschäftsbericht 2023
hinzugefügt 15.03.2024
Brickell Biotech Langfristiger Schuldenstrom 2011-2026 | BBI
Langfristiger Schuldenstrom Jährlich Brickell Biotech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 49 K | 69 K | 74 K | 78 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 78 K | 49 K | 67.5 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
9.06 M | $ 2.19 | -9.77 % | $ 226 M | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
Cabaletta Bio
CABA
|
3.56 M | $ 3.34 | 0.45 % | $ 3.9 M | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Codexis
CDXS
|
2.83 M | $ 1.02 | 1.49 % | $ 74.9 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.74 | 3.6 % | $ 1.12 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
Cerus Corporation
CERS
|
2.28 M | $ 2.6 | 1.37 % | $ 480 M | ||
|
Cellectis S.A.
CLLS
|
8.38 M | $ 3.87 | -0.39 % | $ 116 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
AIkido Pharma
AIKI
|
410 K | - | 1.93 % | $ 17.4 M | ||
|
Collegium Pharmaceutical
COLL
|
1.41 M | $ 41.75 | 0.19 % | $ 1.32 B | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
1.08 M | $ 36.14 | 1.23 % | $ 3.75 B | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Amarin Corporation plc
AMRN
|
1.87 M | $ 13.98 | 1.27 % | $ 5.7 B | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
10.8 M | - | 4.14 % | $ 49.1 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
437 K | $ 23.77 | 2.99 % | $ 2.91 B | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
1.44 M | $ 8.41 | -1.87 % | $ 36.4 M | ||
|
Cardiff Oncology
CRDF
|
730 K | $ 1.94 | 0.01 % | $ 130 M | ||
|
Curis
CRIS
|
1.34 M | $ 1.1 | -3.51 % | $ 6.94 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
CorMedix
CRMD
|
151 K | $ 7.16 | 0.42 % | $ 364 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Champions Oncology
CSBR
|
1.47 M | $ 6.14 | 3.89 % | $ 83.9 M | ||
|
Aravive
ARAV
|
2.2 M | - | -13.39 % | $ 1.45 M | ||
|
Aptose Biosciences
APTO
|
428 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
Citius Pharmaceuticals
CTXR
|
242 K | $ 0.72 | -2.34 % | $ 4.84 M | ||
|
Athira Pharma
ATHA
|
414 K | - | - | $ 269 M | ||
|
Aridis Pharmaceuticals
ARDS
|
538 K | - | 17.91 % | $ 11.1 M | ||
|
Altimmune
ALT
|
279 K | $ 4.21 | -2.32 % | $ 299 M | ||
|
CEL-SCI Corporation
CVM
|
227 K | $ 3.88 | -8.92 % | $ 247 M |